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INTRODUCTION
N-acetylaspartate (NAA) is a brain-
specific metabolite and one of the most
abundant low molecular weight com-
pounds of the human brain having con-
centrations (up to 15 mmol/L) similar 
to those of the neurotransmitter gluta-
mate (1). NAA is synthesized in neurons
from acetyl-CoA and aspartate by aspar-
tate N-acetyltransferase, a membrane-
bound enzyme recently identified as 
N-acetyltransferase 8–like (Nat8l) (2)
which has been associated with endo-
plasmic reticulum (3) rather than mito-
chondria (4). Notwithstanding, the 
mitochondrial localization of NAA
biosynthesis appears strongly corrobo-
rated by the data showing that decrease
in NAA production is affected by mal-
functioning of the mitochondrial aspar-
tate transporter Slc25a12 (solute carrier
family 25 (aspartate/glutamate carrier),
member 12), the activity of which is evi-
dently necessary to guarantee a constant
aspartate supply to mitochondria for
NAA biosynthesis (5). To ensure NAA
turnover, the molecule must move cellu-
lar compartments to reach oligodendro-
cytes (astrocytes participate to a lower
extent in NAA degradation), where it is
degraded into acetate and aspartate by
aspartoacylase (Aspa) (6). Therefore,
NAA has a complex  homeostasis regu-
lated by the rate of biosynthesis by
Nat8l, outflow from neurons, uptake by
oligodendrocytes and degradation by
Aspa. In addition, due to the high indi-
rect energy expenditure necessary to syn-
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thesize NAA, its biosynthesis is in strict
correlation to mitochondrial function and
cell energy state (7).
In spite of the hundreds of studies re-
lated to NAA, its exact biological role is
far from being clearly identified. Source
of acetate for lipid myelin biosynthesis
(8), reservoir of glutamate (9) and regu-
lator of water homeostasis (1) are some
of the main possible cellular functions
in which NAA appears to play a signifi-
cant role. Pathologically, it is known
that the failure in NAA degradation,
due to defective Aspa, causes the
leukodystrophy with fatal prognosis
known as Canavan disease, character-
ized by spongy neurodegeneration, pro-
found mental retardation, with modest
NAA accumulation in the brain and
massive excretion in urine (10). Simi-
larly, in a single patient known at pres-
ent, it has recently been demonstrated
that the inherited defect of Nat8l, caus-
ing a dramatic decrease in cerebral
NAA, is compatible with life but is as-
sociated with truncal ataxia, marked
developmental delay, seizures and sec-
ondary microcephaly (2). Several stud-
ies have clearly demonstrated that
NAA is affected negatively by various
acute and chronic states of neurodegen-
eration, including brain ischemia (11),
stroke (12) multiple sclerosis (13), Alz-
heimer’s disease (14) and others, all
having in common the malfunction of
mitochondria.
A vast number of studies have indi-
cated that the alteration of mitochondr-
ial functions is one of the crucial events
capable of compromising neuronal sur-
vival following traumatic brain injury
(TBI) (15) and leading to cell energy im-
balance (16). In our previous experi-
ments, evidence showed that mild TBI
(mTBI) and severe TBI (sTBI) in the rat
produced a significant NAA depletion,
spontaneously reversible in mTBI only
(16,17). This phenomenon clearly mir-
rored the time-course variations of cere-
bral ATP and mitochondrial phospory-
lating capacity (measured by the
ATP/ADP ratio), both influenced either
by the severity of TBI or by the time
after impact (16,17). These findings con-
firmed the close correlation between
NAA and ATP/mitochondrial function
and suggested that NAA is a valid sur-
rogate marker for an indirect evaluation
of the cerebral energy state. Further-
more, in groups of athletes measured
by proton magnetic resonance spec-
troscopy (1H-MRS), we have shown 
that NAA underwent a transient de-
crease following concussion with a nor-
malization time lasting much longer
than that needed for the postconcussive
symptom disappearance (18). In addi-
tion, we also observed that athletes re-
porting a second concussion during the
recovery process of brain metabolism
had a further NAA depletion accompa-
nied by much longer times for NAA 
replenishment (19).
With the aim of better characterizing
the molecular mechanisms underlying
perturbation of NAA metabolism fol-
lowing graded TBI, we measured 
NAA, ATP and ADP (to calculate the
ATP/ADP ratio as an index of the mito-
chondrial phosphorylating capacity)
and the gene and protein expressions of
the enzymes responsible for NAA ho-
meostasis (NAT8L and ASPA) in brain
tissue extracts from rats receiving either
mTBI or sTBI at different times from 
impact.
MATERIALS AND METHODS
Experimental Protocol
A total of 99 animals was used in this
study. Sample size was determined as-
suming a significantly pathological 20%
change of the parameters under evalua-
tion, with respect to those determined
in controls. With an α value of 5% and
with six values at each time point, a
95% power was achieved. The experi-
mental protocol was approved by the
Ethical Committee of the Catholic Uni-
versity of Rome, according to interna-
tional standards and guidelines for ani-
mal care. Male Wistar rats of 250–300 g
were used in this study. They were ran-
domly divided into three groups: (i)
sham- operated as control; (ii) mild dif-
fuse TBI (mTBI group); and (iii) severe
diffuse TBI (sTBI group). Animals were
anesthetized with intraperitoneal (IP)
injection of propofol 23 mg/kg body
weight. Mild or severe TBI was induced
by dropping a 450-g weight from 1- or 
2-m height, respectively, according to
the weight drop impact acceleration
model (20). These two levels of injury
have been characterized previously his-
tologically and morphologically (20), as
well as biochemically and metabolically
(7,16,17), and classified as mTBI and
sTBI. Rats that suffered from skull frac-
ture, seizures, nasal bleeding or did not
survive the impacts were excluded
from the study. After 6, 12, 24, 48 and
120 h from brain injury, rats (n = 9 for
each time point in each of the two
groups of injured animals) were again
anesthetized and then immediately eu-
thanized. Sham-operated animals acted
as the control group and were eutha-
nized 12 h after the initial anesthesia 
(n = 9).
Preparations of Tissue for Molecular
and Biochemical Analyses
To minimize metabolite loss, an in vivo
craniectomy was performed on all ani-
mals during anesthesia. The rat skull was
carefully removed, the brain exposed
and sharply cut along the sagittal fissure
and the two hemispheres were sepa-
rately freeze clamped by aluminum
tongs precooled in liquid nitrogen and
then immersed in liquid nitrogen. The
freeze-clamping procedure was intro-
duced to accelerate freezing of the tissue,
thus minimizing potential metabolite
loss (21). Total RNA was extracted by ho-
mogenizing one hemisphere in TRIzol
(Invitrogen/ Life Technologies, Carlsbad,
CA, USA), using the ULTRA-TURRAX
homogenizer (Janke & Kunkel, IKA,
Staufen, Germany) at 24,000 rpm/min, to
produce a final 10% homogenate
(weight:volume) according to the manu-
facturers’ instructions.
Crude homogenates suitable for Nat8l
and Aspa quantification were obtained
by homogenizing one hemisphere in 
15 mmol/L KCl + 1 mmol/L KH2PO4,
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pH 7.4, at 24,000 rpm/min for 90 s in 
the cold, followed by centrifugation at
18,690g for 15 min at 4°C.
The tissue preparation for metabolite
analysis was achieved by deproteiniz-
ing one hemisphere according to the 
organic solvent deproteinizing proce-
dure described in details elsewhere
(22).
To obtain simultaneous measure-
ments at each time point of the parame-
ters of interest and to have their meas-
urements in 6 animals at each time
point for both levels of injury, the fol-
lowing scheme of tissue preparation
was performed: 9 animals at each time
point for each level of injury, 18 hemi-
spheres at each time point, 3 right plus
3 left hemispheres were processed for
RNA and protein extractions, 3 right
plus 3 left hemispheres were processed
for RNA and metabolite extractions and
3 right plus 3 left hemispheres were
processed for metabolite and protein
extractions. By use of this protocol for
tissue manipulation and properly mix-
ing the different processing of the right
and left hemispheres, it was possible 
to have a concomitant evaluation of
NAA, gene expression and protein
quantification of Nat8l and Aspa, each
performed in six hemispheres of six dif-
ferent animals.
Analysis of Gene Expression of NAT8L
and ASPA
RNA extracted from brain samples
was reverse transcribed to cDNA by Su-
perscript II Reverse Transcriptase Kit
 (Invitrogen/Life Technologies). From
each sample, 1 μg of total RNA, 50 ng of
oligo dT primers (Roche Molecular Bio-
chemicals [Roche Diagnostics Ltd.,
Burgess Hill, UK]) and 20 U of Super-
script II Reverse Transcriptase, in a total
volume of 20 μL First Strand Buffer,
were incubated at 42°C for 60 min. The
concentration and purity of the result-
ing cDNA was then determined with a
ND-1000 UV-Vis Spectrophotometer
(NanoDrop, Wilmington, DE, USA
[Thermo Fisher Scientific Inc., Waltham,
MA, USA]). Real-time quantitative PCR
(RT-qPCR) with melting curve analysis
was performed in Bio-Rad iQ5 Real-
time PCR Detection System (Bio-Rad,
Hercules, CA, USA). In each reaction,
100 ng of cDNA were mixed with 25 μL
2× SYBR Green PCR Master Mix (Ap-
plied Biosystems/ Life Technologies),
proper primers (300 nmol/L final con-
centration) in a final volume of 50 μL.
The thermal profile began with incuba-
tion at 95°C for 10 min, followed by 40
amplification cycles alternating 94°C for
15 s and 60°C for 60 s. To confirm the
specificity of reactions, a melting curve
was produced by conducting 81 melting
cycles of 30 s every 0.5°C, from 55°C to
95°C. Data were analyzed by the iQ5
Optical System Software (Bio-Rad).
Primers were designed with the 0.2
version of the Primer3 Input software de-
veloped by the Whitehead Institute for
Biomedical Research (Cambridge, MA,
USA) and using as template the se-
quences of Rattus norvegicus NAT8L
(NM_001191681.1) and ASPA
(NM_024399) published by the National
Center for Biotechnology Information
(Bethesda, MD, USA). The following
primer sequences were used: NAT8L
 forward 5′-CCCATGAGGAGGACA
ACACA-3′, NAT8L reverse 5′-TGTGT
CTGAAGCCCAGTGAC-3′; ASPA forward
5′-TCCAAGGAACGAAAGTGGAG-3′,
ASPA reverse 5′-GAGTCTCCACCCAGT
GGAAT-3′. For accurate gene expression
measurements with RT-qPCR, results
were normalized to the housekeeping
gene of ubiquitin C of Rattus norvegicus
(Ubc NM_017314.1), selected using the
geNorm Housekeeping Gene Selection
Kit (Primerdesign Ltd, Rownhams,
Southampton, UK) from twelve candi-
date reference genes. Changes in tran-
script abundance of tested genes (NAT8L,
ASPA) were calculated using the 2–ΔΔCT
method as described by Livak and
Schmittgen (23).
Protein Quantification of Aspa and
Nat8l
Quantification of Aspa and Nat8l
proteins was carried out using
immuno assays enzyme-linked
immuno sorbent assay (ELISA) kits
(Cusabio Biotech, Wuhan, China) ac-
cording to the manufacturer’s instruc-
tions. Briefly, 100 μL of standards and
supernatants of brain homogenates
were incubated in microplate wells pre-
coated with antibody specific for Aspa
or Nat8l. After incubation, biotinyla-
tion and conjugation with streptavidin-
horseradish peroxidase plates were in-
cubated for 30 min at 37°C with
3,3′,5,5′-tetramethylbenzidine. The re-
action was stopped by the addition of
50 μL of acidic solution and absorbance
of the resulting yellow product was
measured spectrophotometrically at
450 nm (Molecular Devices, Sunnyvale,
CA, USA). Using this protocol, the
standard curves were linear and
ranged from 28 pg/mL to 1,800 pg/mL
for Aspa and from 31.25 pg/mL to
2,000 pg/mL for Nat8l.
HPLC Determination of NAA, ATP and
ADP
NAA, ATP and ADP were measured in
20 μL of deproteinized brain extracts by
high performance liquid chromatogra-
phy (HPLC) according to ion-pairing
methods formerly set up in our labora-
tory (22) and using a Hypersil C-18,
250 × 4.6 mm, 5-μm particle size column,
provided with its own guard column
(Thermo Fisher Scientific Inc.). The
HPLC apparatus consisted of a Spec-
traSystem P2000 pump system (Thermo
Fisher Scientific Inc.) and a highly-
 sensitive UV6000LP diode array detector
(Thermo Fisher Scientific Inc.) set up be-
tween 200- and 300-nm wavelength. As-
signment and calculation of NAA and
adenine nucleotides (ATP and ADP)
were carried out at 206 and 260 nm
wavelength, respectively, by comparing
retention times, absorption spectra and
area of the peaks with those of true
NAA, ATP and ADP with known
 concentrations.
Statistical Analysis
The within group comparison at each
time was performed by one-way analy-
sis of variance (ANOVA). Differences
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across groups were estimated by two-
way ANOVA for repeated measures.
The Fisher protected least square was
used as the post hoc test. Differences
were regarded as statistically significant
at a value of p < 0.05.
RESULTS
Effect of Graded TBI on NAA and
Energy Metabolism
To grossly account for the different
severity of injury using this model of TBI,
a mortality rate of 11.8% (6/51 rats) was
recorded in the group of sTBI, while all
mTBI rats survived to the impact for the
desired time. In Figure 1, the time course
changes of NAA (panel A), ATP (panel B)
and ATP/ADP ratio (panel C) in rats fol-
lowing mTBI or sTBI are reported. In
mTBI, minimal values of these parameters
were recorded at 12-h postinjury, with
NAA fully recovering at 120-h postimpact
and ATP and the ATP/ADP ratio showing
no differences from controls already at 
48-h postinjury. In sTBI, sudden NAA,
ATP and ATP/ADP ratio falls were ob-
served at 6-h postimpact, with stable 50%
to 65% decreases recorded hereinafter.
NAA and ATP concentrations, as well as
the mitochondrial phosphorylating capac-
ity (ATP/ADP ratio), were strictly depen-
dent on injury severity, with mTBI rats ac-
counting for higher values of these
parameters at 12-, 24-, 48- and 120-h
postinjury than those determined in sTBI
rats at corresponding times (p < 0.01).
Effect of Graded TBI on Genes
Involved in NAA Homeostasis
As illustrated in Figure 2, TBI affected
the transcript levels of NAT8L depending
on injury severity. In fact, mTBI (panel A)
caused an initial significant NAT8L down-
regulation at 6-h postinjury, followed by a
return to preimpact values and then a sig-
nificant overexpression at 24-, 48- and
120-h postinjury (p < 0.05). By contrast, a
dramatic downregulation of the transcript
for NAT8L was determined following
sTBI (panel B), at early phases after injury
(6 h after TBI) and was not followed by
any type of recovery (mean residual
postinjury levels = 25% of the value of
controls; p < 0.001). Transcript levels for
NAT8L in sTBI rats were significantly
lower at any time after injury than values
recorded in mTBI animals (p < 0.001).
As shown in Figure 3, mTBI (panel A)
caused ASPA expression to increase 2.2
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Figure 1. NAA and energy metabolism after graded TBI. Time course changes of cerebral
concentrations of NAA (A) and ATP (B) and of the value of the ATP/ADP ratio (C), in rats
experiencing diffuse TBI of graded severity ( , mTBI; ¢, sTBI). Values of the parameters at
each time point are the mean of 6 animals (3 left plus 3 right hemispheres) and are ex-
pressed as μmol/g wet weight. Standard deviations are represented by vertical bars. *Sig-
nificantly different from controls (p < 0.05). **Significantly different from the corresponding
time in mTBI rats (p < 0.05). 
times over the basal value (P < 0.001), at
6-h postinjury. This was, however, pur-
sued by a return to preimpact values by
12-h post-mTBI, with no further changes
at the subsequent times. Inducing sTBI to
rats provoked a dramatic 7.2 times over-
expression of the ASPA gene (panel B) al-
ready at 6-h postimpact (p < 0.001 com-
pared with controls). At 12-, 24-, 48- and
120-h postinjury, sTBI animals had an
ASPA overexpression of 4.5, 2.3, 2.2 and
1.7 times than the value of controls (p <
0.001). In comparison with mTBI ani-
mals, rats subjected to sTBI had higher
levels of mRNA for ASPA at any time
point after injury (p < 0.01).
Effect of Graded TBI on Protein Levels
of Nat8l and Aspa
In Figure 4, the time course changes in
the Nat8l protein level recorded in mTBI
rats (panel A) are reported. No differ-
ences with respect to controls were seen
at 6, 12 and 24 h following mTBI, but sig-
nificantly higher Nat8l levels were re-
corded either at 48- or at 120-h postinjury
(p < 0.01), indicating that the increase in
transcript for Nat8l was accompanied by
an increase in the protein synthesis. In
panel B, it is possible to observe that sTBI
rats underwent to a significant decrease
in Nat8l protein levels at 12-, 24-, 48- and
120-h postinjury (p < 0.001), demonstrat-
ing that the dramatic downregulation of
the gene in the severely injured brain
(Figure 2, panel B) hinders restoration of
the amount of the NAA synthesizing en-
zyme at preimpact levels. In addition, at
12-, 24-, 48- and 120-h postinjury, sTBI
rats had significantly lower Nat8l protein
levels than those recorded in mTBI rats at
corresponding times (p < 0.001).
Figure 5 clearly shows that Aspa pro-
tein levels following an mTBI (panel A)
were modestly increased only after 12-
and 24-h postinjury (p < 0.05 with respect
to controls), with no significant differ-
ences compared with controls at the other
time points. Conversely, a massive 1.9-,
3.3-, 2.7- and 2-times increase in Aspa pro-
tein levels following an sTBI (panel B)
were recorded, respectively, at 12-, 24-, 48-
and 120-h postinjury (p < 0.001 compared
with controls). Aspa protein levels higher
than those determined in mTBI at corre-
sponding times were determined after 
24-, 48- and 120-h postinjury (p < 0.001).
To better depict how graded TBI differ-
entially affected the NAA homeostasis,
we reported in Figure 6 the time course
changes occurring to NAA, gene expres-
sion of NAT8L and ASPA, protein levels
of Nat8l and Aspa in rats following either
mTBI (panel A) or sTBI (panel B).
It is worth noting that, in both types of
TBI severity, changes in NAA and gene
expressions of NAT8L and ASPA occurred
at early stages (6 h) after injury, indicat-
ing that parameters controlling the NAA
homeostasis are altered precociously by
the traumatic event. It is evident from the
comparison of the various trends re-
ported in panels A (mTBI) and B (sTBI)
that in mTBI rats the time interval 12- to
24-h postinjury is crucial to trigger the
biochemical processes necessary to re-
store NAA concentrations to preimpact
values, as well as to normalize mitochon-
drial-dependent energy metabolism (see
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Figure 2. Changes of the NAT8L gene expression following graded TBI. Time course changes
of NAT8L cerebral gene expression in rats experiencing diffuse mTBI ( ) or diffuse sTBI (¢).
Values at each time point are the mean of 6 animals (3 left plus 3 right hemispheres) and
are expressed as the NAT8L/UBC ratio, where UBC is the housekeeping gene ubiquitin C.
Standard deviations are represented by vertical bars. *Significantly different from controls
(p < 0.05). **Significantly different from the corresponding time in mTBI rats (p < 0.05).
the time course of ATP in mTBI rats,
panel B of Figure 1). Irreversibility in the
alterations of NAA homeostasis in sTBI is
clearly demonstrated by the protracted
decrease in gene expression of NAT8L
and by the dramatic overexpression of
the ASPA gene, both leading to an irre-
versible decrease in the protein Nat8l lev-
els and a concomitant increase in the
Aspa protein levels. These facts, accom-
panied by persistent mitochondrial dys-
function, as demonstrated by a 50% de-
crease in ATP concentration at 12-, 24-,
48- and 120-postinjury (Figure 1, panel B),
caused a net irreversible NAA depletion
by 50% recorded even at 120-h post-sTBI.
DISCUSSION
In spite of its relative structural simplic-
ity and of its age (it was discovered by Tal-
lan in 1957 [24]), NAA is still an orphan
molecule waiting to be assigned a strictly
convincing precise biological function
(1,8,10). Due to its unique properties of
being brain specific and highly abundant
in the nervous tissue (1), easily measura-
ble ex vivo with proper techniques in any
type of biological sample (17,22), measura-
ble in vivo in human beings by 1H-MRS
thanks to its strong spectroscopic signal
(18,19, 25), affected by several pathological
states of acute and chronic brain suffer-
ance (11–14,25), a relevant number of stud-
ies on this compound are published yearly
indicating a high scientific interest in
NAA. Also in TBI, NAA is thought of in-
creasing importance since it was observed
that NAA concentration is negatively af-
fected by TBI (26,27), with the degree of its
depletion depending on TBI severity (16)
and with the changes mirroring those oc-
curring in energy metabolism, mitochon-
drial phosphorylating capacity and, in
particular, ATP levels (16). Therefore, mea-
suring NAA can now be considered as an
indirect measurement of the brain energy
state and it is of significant utility in deter-
mining the time for a safe return of ath-
letes to play following concussion (18,19).
With these premises, we undertook the
present study with the aim of clarifying
how the complex NAA homeostasis, influ-
enced also by mitochondrial functions and
energy state, is affected by graded TBI. To
this purpose, we took into consideration
NAA and ATP concentrations and values
of the ATP/ADP ratio (as a measure of the
mitochondrial phosphorylating capacity),
as well as the gene expressions and the
protein levels of Nat8l and Aspa, the en-
zymes directly regulating brain NAA ho-
meostasis. A general overview of the time
course changes occurring to NAA and to
the factors affecting its homeostasis after
either mTBI (panel A) or sTBI (panel B) is
depicted in Figure 6. The profound differ-
ences between a mild and a severe TBI are
self-evident: NAA and factors controlling
its homeostasis spontaneously return to
preimpact values in mTBI only.
When observing the kinetics of the dif-
ferent parameters in mTBI rats, it is possi-
ble to elicit a timetable of the cascade of
molecular events that contribute to mod-
ify NAA metabolism. It has previously
been demonstrated that NAA, ATP and
the ATP/ADP ratio undergo a significant
decrement already after 0.5 h (28) or 1 h
(29), that is, during the first time interval
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Figure 3. Changes of the ASPA gene expression following graded TBI. Time course changes
of ASPA cerebral gene expression in rats experiencing diffuse mTBI ( ) or diffuse sTBI (¢).
Values at each time point are the mean of 6 animals (3 left plus 3 right hemispheres) and
are expressed as the ASPA/UBC ratio, where UBC is the housekeeping gene ubiquitin C.
Standard deviations are represented by vertical bars. *Significantly different from controls
(p < 0.05). **Significantly different from the corresponding time in mTBI rats (p < 0.05).
after injury (0–6 h) considered in the pres-
ent study. Therefore, it is conceivable that
the NAA decrease here measured at 6-h
postinjury is only due to the mTBI in-
duced mitochondrial malfunctioning neg-
atively affecting energy metabolism (con-
comitant decrease in ATP and ATP/ADP
ratio), limiting acetyl-CoA availability and
the overall energy expenditure for NAA
biosynthesis. During this period of time,
NAA depletion should mainly reflect the
neuronal energy crisis and its measure-
ment has the meaning of an indirect ATP
measurement. It is very important to ob-
serve that a decrease in the gene expres-
sion of NAT8L and an increase in the gene
expression of ASPA also were observed at
this time point (Figure 6, panel A). The
NAT8L gene downregulation might be an
early occurrence of the recently reported
gene program of neuroprotection, found
in an in vitro model of mild stretch injury
(comparable in damage to mTBI) and
aimed at optimizing ATP consumption in
a period of mitochondrial malfunctioning
(30). Concerning ASPA overexpression, it
may be hypothesized that an increased
rate of NAA efflux from neurons is oper-
ating after mTBI (31). This increase in
NAA, that in time reaches the oligoden-
drocyte cellular compartment where deg-
radation into aspartate and acetate occurs,
might exceed the physiological Aspa de-
grading capacity and might represent the
signal initiating the 2.3 times ASPA over-
expression (see also Figure 3, panel A).
During the 6- to 12-h period following
mTBI a further decrease in NAA, ATP and
ATP/ADP ratio takes place (Figure 1, pan-
els A, B and C and panel A of Figure 6),
with no differences in either gene expres-
sion or protein levels of Nat8l. This addi-
tional NAA decrement may be caused by
the combination of at least two factors: a
protracted impairment of the mitochon -
drial phosphorylating capacity (decreased
ATP/ADP ratio) directly affecting the ATP
synthesis and still causing neuronal en-
ergy deficit, and an increased rate of NAA
degradation in the oligodendrocyte com-
partment caused by an accelerated efflux
from neurons and by an augmentation in
the Aspa protein levels, now capable of ef-
ficiently executing NAA hydrolysis. This
1.6-times increase in Aspa protein was de-
layed by 6 h compared with the ASPA
gene overexpression which, in the 6- to 12-
h period, remained overexpressed com-
pared with the preimpact values. Hence,
at 12-h post-mTBI, NAA depletion proba-
bly reflects not only the neuronal energy
crisis but also the increased Aspa levels
and its measurement still has the meaning
of an indirect ATP measurement, thanks to
the similarity in the changes of these two
compounds (Figure 1, panel A).
The 12- to 24-h period following mTBI
is characterized by an inversion in the
trends of the different parameters under
evaluation and may be considered a cru-
cial period not only for the process of re-
covery of NAA homeostasis, but also for
that of the brain central metabolism. In
fact, it is possible to observe a gradual but
consistent NAA and ATP increase and a
recovery of the ATP/ADP ratio; presum-
ably, higher ATP levels might also be ob-
tained for the effect of the gene program
of neuroprotection aimed at optimizing
ATP consumption (30). The NAT8L gene
expression increased more than 1.6 times
R E S E A R C H  A R T I C L E
M O L  M E D  2 0 : 1 4 7 - 1 5 7 ,  2 0 1 4  |  D I  P I E T R O  E T  A L .  |  1 5 3
Figure 4. Changes of the Nat8l protein level following graded TBI. Time course changes of
cerebral protein levels of Nat8l in rats experiencing diffuse mTBI ( ) or diffuse sTBI (¢). Val-
ues at each time point are the mean of 6 animals (3 left plus 3 right hemispheres). Stan-
dard deviations are represented by vertical bars. *Significantly different from controls (p <
0.05). **Significantly different from the corresponding time in mTBI rats (p < 0.05).
over the preimpact value and the ASPA
gene expression approximated to the
value determined in controls. A slight 
increase in the Nat8l protein levels and a
decrease in that of Aspa (Figure 6, panel A)
was observed during this time interval. At
24-h post-mTBI, the beginning of NAA re-
covery should reflect the benefits of the
cell energy saving obtained by the gene
program of neuroprotection and of the in-
crease and decrease in Nat8l and Aspa
levels, respectively; again, NAA measure-
ment still has the meaning of an indirect
ATP measurement.
The 24- to 48-h post-mTBI period is
characterized by a significant increase in
the NAA, ATP and ATP/ADP ratio (Fig-
ure 1, panels A, B and C). It is evident
(Figure 6, panel A) how the spontaneous
nature of the recovery of the complex
NAA homeostasis is realized during this
period of time by a concomitance of mul-
tiple factors, all acting to the same direc-
tion. In fact, the NAT8L overexpression
(occurred during the previous 12 to 24 h)
led to a 1.4-times increase in the Nat8l
protein levels. In the meantime, either the
gene expression or the protein Aspa lev-
els decreased consistently, thus contribut-
ing to the overall increase of NAA con-
centration. At 48-h post-mTBI, the ad-
vanced NAA recovery probably reflects
the restoration of mitochondrial functions
and the significant increase and decrease
in Nat8l and Aspa protein levels; hence,
determining postinjury NAA normaliza-
tion has the meaning of an indirect mea-
sure of ATP normalization.
The last post-mTBI period considered in
this study (48 to 120 h) is characterized by
normalization of NAA, ATP and the
ATP/ADP ratio (Figure 1, panels A, B and
C), NAT8L and ASPA gene expressions,
Aspa protein levels, with the Nat8l protein
level still higher than controls (Figure 6,
panel A). The full spontaneous recovery of
NAA homeostasis observed at 120-h post-
mTBI then results from the combination of
the restored capacity of mitochondria to
supply cerebral energy demand and the
proper changes in gene expressions and
protein levels of the enzymes controlling
NAA biosynthesis (Nat8l) and degrada-
tion (Aspa). At this time point, measuring
normal NAA is equivalent to measuring
normal ATP and recovered mitochondrial
phosphorylating activity, therefore deter-
mining closure of the window of meta-
bolic brain vulnerability (6,7,18,19,32).
A much simpler timetable could be de-
rived when considering the changes oc-
curring after an sTBI (Figure 6, panel B). It
is worth recalling that it has previously
been demonstrated that the very early de-
creases in NAA, ATP and ATP/ADP ratio
occurring after an sTBI are much more ev-
ident than those observed after an mTBI
(28). Even in the present study, at 6 h we
found significantly lower NAA, ATP and
ATP/ADP ratio levels in sTBI than in
mTBI (Figure 1, panels A, B and C), indi-
cating a more pronounced mitochondrial
dysfunction in the severely injured ani-
mals. To counteract this precocious dra-
matic energy crisis, neurons respond by
repressing expression of the NAT8L gene
to avoid acetyl-CoA consumption for
NAA biosynthesis: this should allow the
use of acetyl-CoA for other reactions of
major importance for cell survival. Rele-
vant loss in neuronal NAA after sTBI
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Figure 5. Changes of the Aspa protein level following graded TBI. Time course changes of
cerebral protein levels of Aspa in rats experiencing diffuse mTBI ( ) or diffuse sTBI (¢). Values
at each time point are the mean of 6 animals (3 left plus 3 right hemispheres). Standard de-
viations are represented by vertical bars. *Significantly different from controls (p < 0.05).
**Significantly different from the corresponding time in mTBI rats (p < 0.05).
should cause a continuous high influx of
this molecule into oligodendrocytes: by
assuming that this is the signal for the
ASPA gene overexpression, it is possible
to explain the more than seven-times in-
crease in the ASPA mRNA occurring at
6-h post-sTBI (Figure 6, panel B).
The 6- to 12-h period following sTBI
produced a further marked decrease in
NAA, ATP and ATP/ADP ratio (Figure 1,
panels A, B and C), a downregulation of
the NAT8L gene, an overexpression by
4.5 times of the ASPA gene, a decrease in
the Nat8l protein levels and the begin-
ning of a relevant increase in the Aspa
protein levels (Figure 6, panel B). There-
fore, all conditions that determine an ir-
reversible loss of NAA homeostasis are
realized after an sTBI: persistent mito-
chondrial malfunctioning with a more
than 65% decrease in their capacity to
phosphorylate ADP into ATP with conse-
quent dramatic energy crisis, repression
of the NAT8L gene with concomitant de-
crease in Nat8l protein synthesis, plus
upregulation of the ASPA gene with in-
crease in Aspa protein synthesis.
The 12- to 24-h post-sTBI are character-
ized by constant NAA, ATP and ATP/
ADP ratio decreases (Figure 1, panels A, 
B and C) and by no change in gene ex-
pression and protein levels of Nat8l (Fig-
ure 6, panel B). By contrast, levels of Aspa
protein increased up to 3.3 times com-
pared with controls, thus promoting the
biochemical conditions suitable to hinder
NAA recovery. The 24 to 48 and the 48 to
120 h periods are featured by unchanged
metabolic conditions, with concentrations
of both NAA and ATP equal to the 50% of
controls and with values of the ATP/ADP
ratio lower than the 70% of those re-
corded in control rats, with minimal gene
expression and protein levels of Nat8l and
with steady upregulation of the ASPA
gene and consequent increased Aspa pro-
tein levels (Figure 6, panel B).
It may be possible that the dramatic
NAA decrease in the case of an sTBI, oc-
curring either in animals (16,28) or in
human beings (27,33), has the meaning of
a desperate attempt by the brain to use
any possible fuel (acetate) with which to
sustain its energy requirement, during a
period of compromised capacity to use
glucose as the main source for energy re-
quirements (34). This might also explain
the exaggerated upregulation of the ASPA
gene leading to a very relevant increase in
the Aspa protein levels. However, con-
cerns about this interpretation can be
raised when thinking that the transforma-
tion of acetate into acetyl-CoA by acetyl-
CoA synthetase is an ATP- dependent re-
action (35) and that it should occur in a
severely injured brain during a period of
profound energy crisis.
Even though these results strongly rein-
forced the link between NAA homeostasis
and ATP/mitochondrial-related energy
state, they do not clarify the biological role
of NAA. To this purpose, the hypothesis
currently considered as the most valid in-
dicates that the sole NAA function,
through its degradation by Aspa within
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Figure 6. Changes of the mechanisms regulating NAA homeostasis after graded TBI. Over-
view of the time course changes of the parameters controlling NAA homeostasis in rats ex-
periencing diffuse mTBI (A) or diffuse sTBI (B). Values of the different parameters at each time
point are the mean of 6 animals (3 left plus 3 right hemispheres). Standard deviations and
significances have been omitted for the sake of clarity. ○, NAA ; ¢,ATP; ●, Nat8l protein lev-
els; ♢, Aspa protein levels.
oligodendrocytes, is to ensure an adequate
acetate supply for lipid myelin biosynthe-
sis (8). This assumption has recently been
questioned (2,3) even though same au-
thors, asserting that the main role of NAA
is to act as an acetate donor, produced ad-
ditional evidences to support their theory
(36). In our opinion, there are some con-
cepts and some considerations that should
be taken into account before considering
this hypothesis valuable. First of all, the
definition given to NAA as a storage mol-
ecule is certainly objectionable, whatever
is its role. A storage molecule, by defini-
tion, should be somehow saved (gluta-
mate, glycogen and so on) and used upon
request thanks to intra- or extracellular
signal(s). It is difficult to accept this con-
cept for NAA which is continuously syn-
thesized and degraded at the rate of 1.44
times per day (1,37) and, up to now, no
specific signals for NAA translocation
from neuronal mitochondria to neuronal
cytoplasm and then from neuronal cyto-
plasm to oligodendrocyte cytoplasm (hy-
pothetically, either via extracellular space
or through a direct neuron → oligoden-
drocyte exchange) have been demon-
strated. Neither have specific NAA trans-
porters ever been isolated. The other
consideration refers to the energetic incon-
venience of using NAA-deriving acetate: 
i) the NAA synthesis requires the acetyl-
CoA hydrolysis (ΔG = –31.5 kJ/mol) and
the waiver to produce 3 NADH and 
1 FADH2 (10–12 ATP); ii) the use of acetate
to form acetyl-CoA is catalyzed by acetyl-
CoA synthetase (35) which, in an energy-
dependent reaction, hydrolyzes ATP into
AMP + Pi-Pi (subsequently hydrolized
into Pi + Pi), with a consequent ΔG = 
–45.6 kJ/mol. Without considering the cost
for NAA generation, the use of free acetate
deriving from NAA hydrolysis (or from
any other source) would cause a ΔG imbal-
ance of 14.1 kJ/mol acetyl-CoA (difference
in the ΔG of the reaction ATP→AMP +
Pi-Pi and acetate + CoA-SH → acetyl-CoA).
According to the literature, NAA turnover
is of 1.44 times/day (1,37); thus, consider-
ing an approximate NAA concentration of
9 μmol/g wet weight, it is easy to calcu-
late that the amount of acetate originating
from NAA hydrolysis is approximately 
13 μmol/g wet weight/ day. Hence, this
could be the maximal acetyl-CoA produc-
tion from NAA hydrolysis for the meta-
bolic necessity of oligodendrocytes. Since
the estimated brain glucose consumption is
of 1,440 to 2,300 μmol/g wet weight/ day
(38), considering that oligodendrocyte glu-
cose consumption is of about 2/5 of the
total (almost equal to that of neurons) (38),
it can be calculated in 288 to 460 μmol/g
wet weight/day the glucose amount con-
sumed by this cell line. Even if only the
60% of the pyruvate produced by glucose
consumption through glycolysis were
transported into mitochondria and oxida-
tively decarboxylated by pyruvate dehy-
drogenase to form acetyl-CoA, it can be
estimated in 173 to 276 × 2 = 346 to
552 μmol/g wet weight/ day the amount
of acetyl-CoA that these cells can generate
from glucose oxidation. Since the maximal
amount of acetyl-CoA that might derive
from NAA hydrolysis is 2.4-3.8% of the
quantity produced from the 60% of oligo-
dendrocyte glucose consumption it is,
again, difficult to admit that the sole bio-
logical role of NAA is that of supporting
acetyl-CoA for the biosynthetic oligoden-
drocyte metabolism (8). It should again be
recalled that acetyl-CoA produced by glu-
cose consumption is energetically much
more convenient than that produced by
free acetate. Last but not least, it is worth
taking into account the relative rates of
lipid myelin biosynthesis and rate of NAA
hydrolysis. In the case of myelin, a need of
about 10 nmol/g wet weight/day of cere-
broside during remyelination is reported
(39), with 12 pairs of carbon atoms needed
for a de novo synthesis of a 24 carbon fatty
acid (one of the most common fatty acid
found in cerebrosides). If the 12 pairs of
carbon atoms were obtained exclusively by
acetate originating from NAA degradation,
a total of 1.2 μmol/g wet weight/day of
NAA must be hydrolyzed to satisfy this
metabolic requirement (it is highly proba-
ble that under physiologic conditions the
rate of myelin synthesis is much slower).
As mentioned earlier, the amount of NAA
hydrolyzed is of about 13 μmol/g wet
weight/day (1,37). If the main and sole bi-
ological role of NAA were that of supply-
ing free acetate from its hydrolysis to be
used for myelin synthesis, then an amount
of exceeding 11.8 μmol/g wet weight/day
of acetate would be produced from NAA
hydrolysis. Such an extraordinary waste of
energy by neurons, producing NAA 12
times over its requirement for myelin syn-
thesis, seems absolutely implausible. It is
certainly conceivable that NAA has multi-
ple functions in brain metabolism, includ-
ing that of a molecular water pump (1),
linked to the metabolism of the neuro-
transmitter N-acetylaspartylglutamate
(40), a reservoir of glutamate (9) and an
acetate donor for oligodendrocytes (8). But
it is also highly possible that the intact
molecule has further unknown biological
functions to justify the energy expenditure
for its continuous turnover.
These present results might also help to
explain why a second concussion occurring
during the recovery phase of NAA home-
ostasis has the effect of remarkably pro-
tracting the time for NAA normalization
(18,19). In fact, if the second concussion
takes place when mitochondrial functions
(mainly, their capacity to phosphorylate
ADP into ATP) are not fully restored and,
when Nat8l and Aspa protein levels are,
respectively, lower and higher than nor-
mal, it is easy to see how the second insult
may cause further depletion of NAA and
further delay in its normalization (18,19).
Additional studies on the mechanisms of
NAA homeostasis, aimed at evaluating
the effects of repeat concussions falling in-
side or outside the window of vulnerabil-
ity, are certainly required.
CONCLUSION
Results of the present study allowed
characterization of the effects of graded
TBI on the mechanisms regulating NAA
homeostasis. Timing of the various mo-
lecular events influencing NAA concen-
trations in the postinjured brain might be
of value either in determining the thera-
peutic windows for the administration of
drugs aimed at modulating the processes
involved in the recovery of NAA homeo-
stasis or in new drug development for
TBI.
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Improving our knowledge of the bio-
logical functions of NAA is likely to im-
prove our understanding of the molecu-
lar events triggered by TBI, possibly
opening new therapeutic windows for
the TBI. It is hard to imagine that NAA,
being such an abundant and energeti-
cally expensive compound, has little bio-
chemical relevance; therefore, efforts
should be made to fully elucidate the
role of this still enigmatic molecule.
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